Orchestra BioMed Holdings (OBIO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Orchestra BioMed Holdings (OBIO) is Neutral.

The composite score behind that read is -0.15, weighing +0.08 of bullish evidence against -0.25 bearish.

Orchestra BioMed Holdings last closed at $6.03, +1.34% on the session.

Against the IVW growth benchmark the position is +0.42% over the forecast window.

The read is built from 11 underlying insights — 3 bullish and 8 bearish.

Agreement across those insights is 73%.

5 graded predictions for OBIO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Orchestra BioMed Holdings in the 7th percentile on return on equity, where 100 is best.

Orchestra BioMed Holdings is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $357.62M.

StockMap tracks Orchestra BioMed Holdings as the 80th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Orchestra BioMed Holdings ranks 52nd of 133 in the group, against a group median of -0.21.